InvestorsHub Logo
Followers 9
Posts 1462
Boards Moderated 0
Alias Born 07/20/2012

Re: antihama post# 57694

Friday, 03/25/2016 4:02:11 PM

Friday, March 25, 2016 4:02:11 PM

Post# of 698814
I agree. And the manufacturing capacity scenario doesn't make sense as an explanation for the screening halt. Also, they have been "ramping up" manufacturing for years in preparation of commercialization. If they aren't yet ready to manufacture on a larger scale, where did all of that money go? I don't buy it.

I think it is far more likely they received a futility rec at the IA based on analysis of PFS (due to the "havoc of pseudos" and everyone taking longer to event, insignificant difference in treatment vs. control) decided to cease enrollment to save resources, but wanted to continue to treat patients already enrolled to analyze possible benefit to subgroups.

It is possible this info was hacked/discovered by shorts which would explain the major drop in Oct and the lack of short covering in the low to mid $1's ever since. The shorts are smug and confident this is going to $0.00 and they may have inside info. Also explains the recent admission by the company that enrollment may never resume. That's my take anyway.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News